We are live on
!
Find out more
PCM
Palisade Capital Management Portfolio holdings
AUM
$3B
1-Year Est. Return
14%
This Fund
S&P 500
This Quarter
Est. Return
+2.15%
1 Year Est. Return
+14%
3 Year Est. Return
+46.63%
5 Year Est. Return
+57.43%
10 Year Est. Return
+263.17%
AUM
$3.93B
AUM Growth
-$48.7M
(-1.2%)
Cap. Flow
-$550M
Cap. Flow
% of AUM
-13.99%
Top 10 Holdings %
Top 10 Hldgs %
10.03%
Holding
559
New
64
Increased
137
Reduced
176
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$23.8M |
| 2 |
Paycom
PAYC
|
+$18.7M |
| 3 |
Burlington
BURL
|
+$15.4M |
| 4 |
Guidewire Software
GWRE
|
+$11M |
| 5 |
CLC
Clarcor
CLC
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
|
+$20.8M |
| 2 |
HCC
HCC INSURANCES HOLDINGS INC
HCC
|
+$19.6M |
| 3 |
IMPV
Imperva, Inc.
IMPV
|
+$18.4M |
| 4 |
DexCom
DXCM
|
+$17.1M |
| 5 |
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
|
+$15.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.16% |
| 2 | Industrials | 12.15% |
| 3 | Healthcare | 10.73% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Standard BioTools
LAB
$321M
| $430K | 0.01% |
+17,755
| New | +$560K |
|
|
MJN
377
DELISTED
Mead Johnson Nutrition Company
MJN
| $424K | 0.01% |
4,699
-8,840
| -65% | -$852K |
|
|
FRM
378
DELISTED
FURMANITE CORPORATION COM
FRM
| $406K | 0.01% |
+50,000
| New | +$411K |
|
379
Pacira BioSciences
PCRX
$1.09B
| $389K | 0.01% |
5,500
+1,250
| +29% | +$98.4K |
|
|
SPR
380
DELISTED
Spirit AeroSystems
SPR
| $386K | 0.01% |
7,000
-5,000
| -42% | -$268K |
|
|
CAM
381
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $349K | 0.01% |
6,660
-2,195
| -25% | -$114K |
|
|
AAC
382
DELISTED
AAC Holdings
AAC
| $348K | 0.01% |
8,000
-32,000
| -80% | -$1.18M |
|
|
STRM
383
DELISTED
Streamline Health Solutions
STRM
| $343K | 0.01% |
8,167
| – | – |
|
|
ALTA
384
DELISTED
Altabancorp
ALTA
| $340K | 0.01% |
+20,000
| New | +$334K |
|
|
PTX
385
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $340K | 0.01% |
+5,750
| New | +$406K |
|
386
BioMarin Pharmaceuticals
BMRN
$11.7B
| $338K | 0.01% |
+2,468
| New | +$306K |
|
387
Aflac
AFL
$63.7B
| $336K | 0.01% |
10,800
-1,800
| -14% | -$57K |
|
388
Microsoft
MSFT
$3.66T
| $329K | 0.01% |
7,455
| – | – |
|
389
Element Solutions
ESI
$9.48B
| $313K | 0.01% |
+12,225
| New | +$330K |
|
390
Super Micro Computer
SMCI
$20.5B
| $296K | 0.01% |
+100,000
| New | +$329K |
|
391
Incyte
INCY
$24.4B
| $292K | 0.01% |
+2,800
| New | +$290K |
|
392
Metallus
MTUS
$897M
| $287K | 0.01% |
10,650
-1,800
| -14% | -$53.1K |
|
|
CTRA
393
DELISTED
Coterra Energy
CTRA
| $285K | 0.01% |
9,029
-3,833
| -30% | -$128K |
|
|
PFSW
394
DELISTED
PFSweb, Inc.
PFSW
| $277K | 0.01% |
+20,000
| New | +$266K |
|
395
Novartis
NVS
$291B
| $275K | 0.01% |
3,120
| – | – |
|
396
Masco
MAS
$15.2B
| $267K | 0.01% |
11,380
| – | – |
|
397
Carnival Corporation Ltd
CCL
$40.5B
| $263K | 0.01% |
+5,325
| New | +$251K |
|
|
HA
398
DELISTED
Hawaiian Holdings, Inc.
HA
| $261K | 0.01% |
11,000
-8,077
| -42% | -$189K |
|
|
LVLT
399
DELISTED
Level 3 Communications Inc
LVLT
| $257K | 0.01% |
+4,875
| New | +$267K |
|
400
Dover
DOV
$28.3B
| $253K | 0.01% |
+4,463
| New | +$266K |
|
Similar funds
DIG
ROTUOC
NC
B
BSA
CI
BGDI
SGI
Palisade Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Palisade Capital Management held 559 positions worth $3.93B, down 1.2% from $3.98B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Palisade Capital Management withdrew a net $550M in Q2 2015, closing 35 positions and reducing 176 holdings. Its most notable exit was ACTAVIS PLC Pfd Conv Ser A (Irl), an estimated $20.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Palisade Capital Management opened a new position in Allergan plc worth $23.7M.
- Palisade Capital Management's largest Q2 2015 buy was Allergan plc: 22,729 shares worth $23.7M.
- Palisade Capital Management added most to Burlington in Q2 2015, an estimated $15.4M increase.
- Palisade Capital Management's biggest Q2 2015 reduction was HCC INSURANCES HOLDINGS INC, cutting an estimated $19.6M.
- Palisade Capital Management fully exited ACTAVIS PLC Pfd Conv Ser A (Irl) in Q2 2015, selling an estimated $20.8M.
- Palisade Capital Management's ten largest holdings make up 10% of its $3.93B portfolio in Q2 2015.
- Palisade Capital Management opened 64 new positions and closed 35 in Q2 2015.
- Palisade Capital Management's portfolio value fell 1.2% quarter-over-quarter to $3.93B.
Based on Palisade Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.